Manage your formulary budget
Anticipate generic drug launch
Deep knowledge on
small-molecule drugs and
the 110,000 global patents
Find generic entry opportunities
Drug patents …
… from Kazakhstan to Kalamazoo
Proactively manage your pharmacy inventory
Flat-rate pricing for predictable budgeting
Short-term plans for project- or client-based billing
Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing
|Title:||Technetium-99m labeled radiopharmaceutical kit for imaging|
|Abstract:||The invention relates to radiolabeled imaging of a mammalian body. The invention in particular provides for reagents labeled with technetium-99m for such imaging. The invention provides peptides which bind technetium-99m and which can be targeted to specific sites within a mammalian body.|
|Inventor(s):||Dean; Richard T. (Bedford, NH)|
|Assignee:||Diatide, Inc. (Londonderry, NH)|
|Filing Date:||Jun 05, 1995|
|Claims:||1. A kit for preparing a radiopharmaceutical that is a scintigraphic imaging agent for imaging target sites within a mammalian body, said kit comprising a sealed vial containing a predetermined quantity of a reagent for preparing the scintigraphic imaging agent, wherein the reagent comprises, in combination: |
(a) a specific binding peptide comprising 3 to 100 amino acids that specifically binds to the target site to be imaged and
(b) a technetium-99 m binding moiety of the formula
wherein Cp is a cysteine amino acid residue and (aa) is any amino acid and wherein the technetium-99 m binding moiety is covalently bound to the specific binding peptide to comprise the reagent, and a sufficient amount of reducing agent to label said reagent with technetium-99 m.
2. A kit according to claim 1 wherein the reagent comprises a specific binding peptide and a Cp(aa)Cp moiety that are covalently linked through from about one to about ninety amino acids.
3. A kit according to claim 1 wherein the reagent comprises a technetium-99 m binding moiety wherein the sidechain sulfur atom of the cysteine residue of the technetium-99 m binding moiety is protested by a protecting group of the formula
wherein R is a lower alkyl having 1 to 6 carbon atoms, phenyl, or phenyl substituted with lower alkyl, hydroxy, lower alkoxy, carboxy, or lower alkoxycarbonyl, or 2-,3-,4- pyridyl.
4. A kit according to claim 1 wherein the reagent comprises a technetium-99 m binding moiety having the formula: ##STR8##
5. A kit according to claim 1 wherein the reagent comprises a specific binding peptide selected from the group consisting of peptides having the formula:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.